Literature DB >> 25801726

Parameters influence on acceleration and deceleration capacity based on trans-abdominal ECG in early fetal growth restriction at different gestational age epochs.

Tamara Stampalija1, Daniela Casati2, Marcella Montico3, Roberto Sassi4, Massimo W Rivolta4, Valeria Maggi2, Axel Bauer5, Enrico Ferrazzi2.   

Abstract

OBJECTIVE: Intrauterine growth restriction (IUGR) is characterized by chronic nutrient deprivation and hypoxemia that alters the autonomous nervous system regulation of fetal heart rate variability (fHRV). Phase-rectified signal averaging (PRSA) is a new algorithm capable to identify periodic and quasi-periodic patterns of HR, and which is used to quantify the average acceleration and deceleration capacity (AC/DC) of the heart. The computation of AC/DC depends on the parameters T and s, which we set so that s=T. T and s determine the periodicities that can be detected (the larger T the smaller the frequency of oscillations for which the method is most sensitive). The aim of the study was to evaluate the influence of the parameter T on PRSA computation, based on trans-abdominally acquired fetal ECG (ta-fECG), in early IUGR (<34 weeks of gestation) at two different gestational age epochs. STUDY
DESIGN: AC/DC were calculated for different T values (1÷45) on fetal RR intervals derived from ta-fECG in 22 IUGR and in 37 appropriate for gestational age (AGA) fetuses matched for gestational age, in two gestational age epochs: very preterm group (≥26÷<30 weeks), and preterm group (≥30÷<34 weeks), respectively.
RESULTS: AC/DC were significantly lower in IUGR than in AGA fetuses for all T≥5 values (p<0.05). The best area under the receiver operating characteristic curve (AUC) in identifying IUGR at time of recording was observed for T9 [AUC AC-T9 0.87, 95% confidence interval (CI) 0.77-0.96; and AUC DC-T9 0.89, 95% CI 0.81-0.98), and in range of T 7÷15. In the same T interval, AC/DC were significantly lower in very preterm than in preterm IUGR group (p<0.05), while there were no differences in AGA fetuses at two gestational age epochs (p>0.05), respectively. The AUCs of AC-T9 and DC-T9 significantly outperformed that obtained by short-term variation (AUC 0.77, 95% CI 0.65-0.90; p=0.009 and p=0.003, respectively).
CONCLUSIONS: Our study shows that within the range of T parameter 1÷45, T=9 proved to be the best value to discriminate the AC and DC of the fetal heart rate of IUGR from AGA fetuses prior to 34 weeks of gestation. These significant differences are emphasized in very preterm gestational age epochs.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Fetal ECG; Fetal growth restriction; Fetal monitoring; PRSA; Short term variation

Mesh:

Year:  2015        PMID: 25801726     DOI: 10.1016/j.ejogrb.2015.03.003

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  10 in total

1.  Do the deceleration/acceleration capacities of heart rate reflect cardiac sympathetic or vagal activity? A model study.

Authors:  Qing Pan; Gongzhan Zhou; Ruofan Wang; Guolong Cai; Jing Yan; Luping Fang; Gangmin Ning
Journal:  Med Biol Eng Comput       Date:  2016-04-08       Impact factor: 2.602

Review 2.  The Critical Role of the Central Autonomic Nervous System in Fetal-Neonatal Transition.

Authors:  Sarah B Mulkey; Adre Dú Plessis
Journal:  Semin Pediatr Neurol       Date:  2018-06-20       Impact factor: 1.636

3.  Evaluation of Abdominal Fetal Electrocardiography in Early Intrauterine Growth Restriction.

Authors:  Clarissa L Velayo; Kiyoe Funamoto; Joyceline Noemi I Silao; Yoshitaka Kimura; Kypros Nicolaides
Journal:  Front Physiol       Date:  2017-06-26       Impact factor: 4.566

4.  Comparison of diurnal variations, gestational age and gender related differences in fetal heart rate (FHR) parameters between appropriate-for-gestational-age (AGA) and small-for-gestational-age (SGA) fetuses in the home environment.

Authors:  Habiba Kapaya; Richard Jacques; Dilly Anumba
Journal:  PLoS One       Date:  2018-03-09       Impact factor: 3.240

5.  A Comprehensive Evaluation of the Predictive Abilities of Fetal Electrocardiogram-Derived Parameters during Labor in Newborn Acidemia: Our Institutional Experience.

Authors:  Ning Tian; Weiyuan Zhang
Journal:  Biomed Res Int       Date:  2018-05-17       Impact factor: 3.411

6.  Differences in the Asymmetry of Beat-to-Beat Fetal Heart Rate Accelerations and Decelerations at Preterm and Term Active Labor.

Authors:  Carolina López-Justo; Adriana Cristina Pliego-Carrillo; Claudia Ivette Ledesma-Ramírez; Hugo Mendieta-Zerón; Miguel Ángel Peña-Castillo; Juan Carlos Echeverría; Jorge Rodríguez-Arce; José Javier Reyes-Lagos
Journal:  Sensors (Basel)       Date:  2021-12-10       Impact factor: 3.576

7.  An integrated approach based on advanced CTG parameters and Doppler measurements for late growth restriction management.

Authors:  Giovanni Magenes; Giuseppe Maria Maruotti; Maria Gabriella Signorini; Giuseppina Esposito; Nicolò Pini; Salvatore Tagliaferri; Marta Campanile; Fulvio Zullo
Journal:  BMC Pregnancy Childbirth       Date:  2021-11-16       Impact factor: 3.007

8.  Relationship Between Deceleration Morphology and Phase Rectified Signal Averaging-Based Parameters During Labor.

Authors:  Massimo W Rivolta; Moira Barbieri; Tamara Stampalija; Roberto Sassi; Martin G Frasch
Journal:  Front Med (Lausanne)       Date:  2021-11-25

Review 9.  Fetal growth restriction and stillbirth: Biomarkers for identifying at risk fetuses.

Authors:  Victoria J King; Laura Bennet; Peter R Stone; Alys Clark; Alistair J Gunn; Simerdeep K Dhillon
Journal:  Front Physiol       Date:  2022-08-19       Impact factor: 4.755

10.  Evaluation of the Acceleration and Deceleration Phase-Rectified Slope to Detect and Improve IUGR Clinical Management.

Authors:  Salvatore Tagliaferri; Andrea Fanelli; Giuseppina Esposito; Francesca Giovanna Esposito; Giovanni Magenes; Maria Gabriella Signorini; Marta Campanile; Pasquale Martinelli
Journal:  Comput Math Methods Med       Date:  2015-12-08       Impact factor: 2.238

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.